Xinhua\u00a0<\/p>\n\n\n\n
NEW DELHI – China’s Sinopharm COVID-19 vaccine, the first non-Western vaccine supported by the World Health Organization (WHO), is likely to be used in the COVAX program, which provides vaccines to low- and middle-income countries, reported the Indian Express newspaper Thursday.<\/p>\n\n\n\n
The WHO last week validated the China-developed vaccine for emergency use, a move set to further expand global vaccine accessibility.<\/p>\n\n\n\n
According to the WHO, Sinopharm has an efficacy of about 79 percent for symptomatic and hospitalised disease for all age groups. However, it notes that since few adults aged over 60 were enrolled, the efficacy in the age group is not clear, said an article in the paper.<\/p>\n\n\n\n
The Sinopharm vaccine is an inactivated coronavirus vaccine, which takes the disease-carrying virus (SARS-CoV-2) and kill it utilizing heat, chemicals or radiation, it said, quoting the WHO as saying that these vaccines take longer to make and might need two or three jabs to be administered.<\/p>\n\n\n\n
The WHO has not recommended an upper age limit on the use of this vaccine “because preliminary data and supportive immunogenicity data suggest the vaccine is likely to have a protective effect in older persons. There is no theoretical reason to believe that the vaccine has a different safety profile in older and younger populations,” said the report.<\/p>\n\n\n\n
The WHO has recommended that the vaccine be administered to adults aged 18 and above in a two-dose schedule with a gap of three to four weeks, it said.<\/p>","protected":false},"excerpt":{"rendered":"
Xinhua\u00a0 NEW DELHI – China’s Sinopharm COVID-19 vaccine, the first non-Western vaccine supported by the World Health Organization (WHO), is likely to be used in the COVAX program, which provides vaccines to low- and middle-income countries, reported the Indian Express newspaper Thursday. The WHO last week validated the China-developed vaccine […]<\/p>","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_themeisle_gutenberg_block_has_review":false,"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_newsletter_tier_id":0,"jetpack_publicize_message":"","jetpack_is_tweetstorm":false,"jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","enabled":false}}},"categories":[28],"tags":[],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":2190,"url":"https:\/\/www.govisachina.com\/zh\/2021\/05\/10\/who-approval-of-sinopharm-vaccine-set-to-benefit-world-coronavirus-fight\/","url_meta":{"origin":2202,"position":0},"title":"WHO approval of Sinopharm vaccine set to benefit world coronavirus fight","author":"Visa China","date":"5\u6708 10, 2021","format":false,"excerpt":"By BO LEUNG in London The World Health Organization's approval to give emergency use to the COVID-19 vaccine manufactured by China's Sinopharm has been welcomed by experts and health regulators worldwide. On Friday, the WHO gave the vaccine the green light, paving the way for potentially millions of doses to\u2026","rel":"","context":"\u5728\u201cCOVID-19\u201d\u4e2d","block_context":{"text":"COVID-19","link":"https:\/\/www.govisachina.com\/zh\/category\/covid-19\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":2421,"url":"https:\/\/www.govisachina.com\/zh\/2021\/07\/30\/roundup-chinese-covid-19-vaccines-effective-against-infection-mortality\/","url_meta":{"origin":2202,"position":1},"title":"Roundup: Chinese COVID-19 vaccines effective against infection, mortality","author":"Visa China","date":"7\u6708 30, 2021","format":false,"excerpt":"BUENOS AIRES, July 30 (Xinhua) -- Experts in viral diseases and infectology have highlighted the efficacy of Chinese vaccines against COVID-19 and its new variants. \"According to the evidence available so far, vaccines that have been licensed by the World Health Organization (WHO) are effective against all variants in circulation\u2026","rel":"","context":"\u7c7b\u4f3c\u6587\u7ae0","block_context":{"text":"\u7c7b\u4f3c\u6587\u7ae0","link":""},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":2401,"url":"https:\/\/www.govisachina.com\/zh\/2021\/07\/13\/providing-500-mln-vaccine-doses-to-world-china-aims-to-enhance-intl-cooperation-against-covid-19\/","url_meta":{"origin":2202,"position":2},"title":"Providing 500 mln vaccine doses to world, China aims to enhance int’l cooperation against COVID-19","author":"Visa China","date":"7\u6708 13, 2021","format":false,"excerpt":"BEIJING, July 13 (Xinhua) -- Chinese vaccines are gathering steam across the world, injecting strong impetus into the global fight against COVID-19 as deaths from the virus topped 4 million worldwide and variants spread to more than 100 countries. As a steadfast advocate for equitable vaccine distribution around the globe,\u2026","rel":"","context":"\u5728\u201cCOVID-19\u201d\u4e2d","block_context":{"text":"COVID-19","link":"https:\/\/www.govisachina.com\/zh\/category\/covid-19\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":2373,"url":"https:\/\/www.govisachina.com\/zh\/2021\/06\/21\/chinas-sinopharm-covid-19-vaccines-arrive-in-thailand\/","url_meta":{"origin":2202,"position":3},"title":"China’s Sinopharm COVID-19 vaccines arrive in Thailand","author":"Visa China","date":"6\u6708 21, 2021","format":false,"excerpt":"BANGKOK, June 20 (Xinhua) -- A batch of China's Sinopharm COVID-19 vaccines landed in the Thai capital of Bangkok Sunday, increasing support to the Southeast Asian country's battle against its worst wave of outbreak so far. The shipment, imported by the Chulabhorn Royal Academy (CRA), was transported to the Department\u2026","rel":"","context":"\u5728\u201cCOVID-19\u201d\u4e2d","block_context":{"text":"COVID-19","link":"https:\/\/www.govisachina.com\/zh\/category\/covid-19\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":2314,"url":"https:\/\/www.govisachina.com\/zh\/2021\/06\/02\/who-validates-chinas-sinovac-covid-19-vaccine-for-emergency-use\/","url_meta":{"origin":2202,"position":4},"title":"WHO validates China’s Sinovac COVID-19 vaccine for emergency use","author":"Visa China","date":"6\u6708 2, 2021","format":false,"excerpt":"GENEVA, June 1 (Xinhua) The World Health Organization (WHO) validated on Tuesday the CoronaVac COVID-19 vaccine developed by Chinese pharmaceutical company Sinovac for emergency use. \"I am happy to announce that the Sinovac coronavirus vaccine has been given WHO Emergency Use Listing (EUL) after being found to be safe, effective,\u2026","rel":"","context":"\u5728\u201cCOVID-19\u201d\u4e2d","block_context":{"text":"COVID-19","link":"https:\/\/www.govisachina.com\/zh\/category\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":2467,"url":"https:\/\/www.govisachina.com\/zh\/2021\/08\/20\/malaysia-takes-first-delivery-of-chinas-cansino-covid-19-vaccine\/","url_meta":{"origin":2202,"position":5},"title":"Malaysia takes first delivery of China’s CanSino COVID-19 vaccine","author":"Visa China","date":"8\u6708 20, 2021","format":false,"excerpt":"KUALA LUMPUR, Aug. 20 (Xinhua) -- The first batch of the single-dose COVID-19 vaccine developed by Chinese company CanSino Biologics arrived in Malaysia on Friday, boosting the country's capability in the fight against the pandemic. The first batch, comprising some 200,000 finished products, is part of a total of 3.5\u2026","rel":"","context":"\u5728\u201cCOVID-19\u201d\u4e2d","block_context":{"text":"COVID-19","link":"https:\/\/www.govisachina.com\/zh\/category\/covid-19\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/posts\/2202"}],"collection":[{"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/comments?post=2202"}],"version-history":[{"count":1,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/posts\/2202\/revisions"}],"predecessor-version":[{"id":2203,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/posts\/2202\/revisions\/2203"}],"wp:attachment":[{"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/media?parent=2202"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/categories?post=2202"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/tags?post=2202"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}